Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Camilla Kriegbaum

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
World Journal of Clinical Oncology|October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
International Journal of Cancer|July 28, 2011
Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Eric Santoni-Rugiu, Martin Illemann, et al.
Scientific Reports|May 13, 2016
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypesMette Camilla Kriegbaum, Benedikte Jacobsen, Annette Füchtbauer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
World Journal of Clinical Oncology|October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
International Journal of Cancer|July 28, 2011
Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Eric Santoni-Rugiu, Martin Illemann, et al.
Scientific Reports|May 13, 2016
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypesMette Camilla Kriegbaum, Benedikte Jacobsen, Annette Füchtbauer, et al.
Pageof 1